clinical trial · NCT00489346
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
Organon and Co·phase3·completed·n = 994
Asthma, BronchialMK0476, montelukast sodium / Duration of Treatment: 1 YearComparator : fluticasone propionate / Duration of Treatment: 1 Year
brief summary
A study to evaluate MK0476 and Fluticasone to control asthma in patients with mild persistent asthma.
started
Oct 1, 2001
primary completion
Jun 1, 2002
completion
Jun 1, 2002
last updated
Aug 15, 2024
official title
A Double-Blind, Randomized, Double-Dummy, Multicenter Study to Evaluate and Compare Oral Montelukast and Inhaled Fluticasone in the Control of Asthma for 6- to 14-Year-Olds With Mild Persistent Asthma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol